查看購物車
  • English
封面
市場調查報告書
商品編碼
1905391

日本生物樣本庫市場報告（按樣本類型、生物樣本庫類型、應用、最終用戶和地區分類，2026-2034年）

Japan Biobanking Market Report by Specimen Type, Biobank Type, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年，日本生物樣本庫市場規模達39.703億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到57.397億美元，2026年至2034年間的複合年成長率（CAGR）為4.18%。對個人化醫療日益成長的需求，以及為支持研究和開發客製化療法而對生物樣本和資料的需求不斷成長，是推動市場成長的主要因素。

本報告解答的關鍵問題：

  • 日本生物樣本庫市場目前的表現如何？未來幾年又將如何發展？
  • 新冠疫情對日本生物樣本庫市場產生了哪些影響？
  • 日本生物樣本庫市場依樣本類型分類的組成是怎樣的？
  • 日本生物樣本庫市場依生物樣本庫類型分類的組成是怎樣的？
  • 日本生物樣本庫市場依應用領域分類的組成是怎樣的？
  • 日本生物樣本庫市場依最終使用者分類的組成是怎樣的？
  • 日本生物樣本庫市場價值鏈的各個階段有哪些？
  • 日本生物樣本庫的關鍵促進因素和挑戰是什麼？
  • 日本生物樣本庫市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本生物樣本庫市場的競爭程度如何？

目錄

第1章：序言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 數據來源
  • 市場估算
  • 預測方法

第3章：執行概要

第4章：日本生物樣本庫市場－簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭情報

第5章：日本生物樣本庫市場概況

  • 歷史及當前市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本生物樣本庫市場－依樣本類型分類

  • 血液製品
  • 實體組織
  • 細胞系
  • 核酸
  • 其他

第7章：日本生物樣本庫市場－依生物樣本庫類型分類

  • 基於人群的生物樣本庫
  • 以疾病為導向的生物樣本庫

第8章：日本生物樣本庫市場－依應用領域分類

  • 療法
  • 研究

第9章：日本生物樣本庫市場－以最終用戶分類

  • 學術機構
  • 製藥和生物技術公司

第10章：日本生物樣本庫市場－按地區分類

  • 關東地區
  • 關西/近畿地區
  • 中部/中部地區
  • 九州·沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第11章：日本生物樣本庫市場－競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳制勝策略
  • 競爭格局分析
  • 公司評估象限

第12章：關鍵參與者簡介

第13章：日本生物樣本庫市場－產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第14章：附錄

簡介目錄
Product Code: SR112026A18685

Japan biobanking market size reached USD 3,970.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 5,739.7 Million by 2034, exhibiting a growth rate (CAGR) of 4.18% during 2026-2034. The increasing demand for personalized medicine, coupled with the growing need for biological samples and data to support research and the development of tailored treatments, is driving the market.

Biobanking is a crucial aspect of modern healthcare and scientific research. It involves the systematic collection, storage, and management of biological samples, such as blood, tissue, and DNA, from individuals for future use in research, diagnostics, and treatment development. Biobanks play a vital role in advancing our understanding of diseases, genetics, and personalized medicine. These repositories preserve specimens and their associated data under strict ethical and regulatory guidelines, ensuring patient privacy and informed consent. Biobanked samples serve as valuable resources for studying diseases, identifying biomarkers, and testing new therapies. They facilitate large-scale, longitudinal studies that can uncover patterns and trends in health and disease over time. Biobanking promotes collaboration among researchers, accelerates medical discoveries, and enhances the potential for tailored treatments based on an individual's genetic makeup. It also supports translational research, bridging the gap between laboratory findings and clinical applications. In summary, biobanking is a critical infrastructure in modern healthcare, advancing medical knowledge and improving patient care.

Japan Biobanking Market Trends:

The biobanking market in Japan is experiencing robust growth due to several key drivers. Firstly, advancements in medical research and the increasing focus on personalized medicine have propelled the demand for biobanking services. These repositories of biological samples enable researchers to access a diverse range of specimens, accelerating their efforts in understanding diseases and developing targeted therapies. Moreover, the growing awareness of the importance of preserving biological materials for future research has prompted both public and private sector investments in biobanking infrastructure. In addition to this, the rising prevalence of chronic diseases, such as cancer and cardiovascular conditions, necessitates extensive biobanking to support the discovery of biomarkers and therapeutic targets. The adoption of genomic medicine and the integration of genetic information into healthcare practices have further amplified the demand for biobanking solutions. Lastly, regulatory initiatives and ethical considerations have strengthened the framework surrounding biobanking, instilling confidence among stakeholders and encouraging their participation. These interconnected drivers are propelling the biobanking market in Japan towards unprecedented growth, promising a future of improved healthcare outcomes and medical breakthroughs.

Japan Biobanking Market Segmentation:

Specimen Type Insights:

  • Blood Products
  • Solid Tissue
  • Cell Lines
  • Nucleic Acid
  • Others

Biobank Type Insights:

  • Population-based Biobanks
  • Disease-oriented Biobanks

Application Insights:

  • Therapeutics
  • Research

End User Insights:

  • Academic Institutions
  • Pharma and Biotech Companies

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan biobanking market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan biobanking market?
  • What is the breakup of the Japan biobanking market on the basis of specimen type?
  • What is the breakup of the Japan biobanking market on the basis of biobank type?
  • What is the breakup of the Japan biobanking market on the basis of application?
  • What is the breakup of the Japan biobanking market on the basis of end user?
  • What are the various stages in the value chain of the Japan biobanking market?
  • What are the key driving factors and challenges in the Japan biobanking?
  • What is the structure of the Japan biobanking market and who are the key players?
  • What is the degree of competition in the Japan biobanking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biobanking Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Biobanking Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Biobanking Market - Breakup by Specimen Type

  • 6.1 Blood Products
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Solid Tissue
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Cell Lines
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Nucleic Acid
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2020-2025)
    • 6.5.2 Market Forecast (2026-2034)

7 Japan Biobanking Market - Breakup by Biobank Type

  • 7.1 Population-based Biobanks
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Disease-oriented Biobanks
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)

8 Japan Biobanking Market - Breakup by Application

  • 8.1 Therapeutics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Research
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)

9 Japan Biobanking Market - Breakup by End User

  • 9.1 Academic Institutions
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Pharma and Biotech Companies
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)

10 Japan Biobanking Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Specimen Type
    • 10.1.4 Market Breakup by Biobank Type
    • 10.1.5 Market Breakup by Application
    • 10.1.6 Market Breakup by End User
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kansai/Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Specimen Type
    • 10.2.4 Market Breakup by Biobank Type
    • 10.2.5 Market Breakup by Application
    • 10.2.6 Market Breakup by End User
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Specimen Type
    • 10.3.4 Market Breakup by Biobank Type
    • 10.3.5 Market Breakup by Application
    • 10.3.6 Market Breakup by End User
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Specimen Type
    • 10.4.4 Market Breakup by Biobank Type
    • 10.4.5 Market Breakup by Application
    • 10.4.6 Market Breakup by End User
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Specimen Type
    • 10.5.4 Market Breakup by Biobank Type
    • 10.5.5 Market Breakup by Application
    • 10.5.6 Market Breakup by End User
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Specimen Type
    • 10.6.4 Market Breakup by Biobank Type
    • 10.6.5 Market Breakup by Application
    • 10.6.6 Market Breakup by End User
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Specimen Type
    • 10.7.4 Market Breakup by Biobank Type
    • 10.7.5 Market Breakup by Application
    • 10.7.6 Market Breakup by End User
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Specimen Type
    • 10.8.4 Market Breakup by Biobank Type
    • 10.8.5 Market Breakup by Application
    • 10.8.6 Market Breakup by End User
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Biobanking Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Biobanking Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix